VELA Investment Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
25,028
-68
-0.3% -$5.48K 0.46% 70
2026
Q1
$1.77M Buy
25,096
+1,652
+7% +$124K 0.41% 78
2025
Q4
$1.85M Sell
23,444
-1,829
-7% -$145K 0.44% 75
2025
Q3
$2.08M Buy
25,273
+3,535
+16% +$278K 0.51% 66
2025
Q2
$1.75M Buy
21,738
+2,193
+11% +$169K 0.47% 66
2025
Q1
$1.57M Buy
19,545
+17
+0.1% +$1.41K 0.49% 71
2024
Q4
$1.6M Sell
19,528
-25
-0.1% -$2.08K 0.45% 78
2024
Q3
$1.61M Buy
19,553
+14
+0.1% +$1.05K 0.5% 72
2024
Q2
$1.37M Buy
19,539
+1,995
+11% +$142K 0.43% 83
2024
Q1
$1.3M Buy
17,544
+1,543
+10% +$108K 0.44% 76
2023
Q4
$1.06M Hold
16,001
0.4% 86
2023
Q3
$1.01M Hold
16,001
0.44% 77
2023
Q2
$905K Hold
16,001
0.42% 86
2023
Q1
$927K Buy
16,001
+5,236
+49% +$353K 0.42% 81
2022
Q4
$779K Buy
10,765
+1,505
+16% +$108K 0.38% 83
2022
Q3
$563K Hold
9,260
0.32% 95
2022
Q2
$581K Hold
9,260
0.33% 83
2022
Q1
$651K Hold
9,260
0.41% 73
2021
Q4
$579K Buy
+9,260
New +$581K 0.39% 76

Other funds holding MET

VELA Investment Management's MET Position: Q2 2026 in Review

VELA Investment Management reduced its MetLife (MET) stake by 0.27% in Q2 2026, selling an estimated $5.48K and leaving 25,028 shares worth $2.12M. The position accounts for 0.46% of the portfolio, ranked #70.

VELA Investment Management first reported a position in MET in Q4 2021 and has held it in 19 quarters since. 1,449 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • VELA Investment Management held 25,028 shares of MetLife worth $2.12M as of Q2 2026.
  • VELA Investment Management sold 68 MetLife shares in Q2 2026, an estimated $5.48K.
  • MetLife made up 0.46% of VELA Investment Management's portfolio in Q2 2026, its #70 holding.
  • VELA Investment Management first reported a position in MetLife in Q4 2021 and has held it in 19 quarters since.
  • 1,449 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on VELA Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.